Abstract
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
References
References 1. Friedman B, Orlet HK, Still JM, Law E. Toxic epidermal necrolysis due to administration of celecoxib (Celebrex). South Med J 2002; 95: 1213–1214.FriedmanB]]OrletHK]]StillJM]]LawEToxic epidermal necrolysis due to administration of celecoxib (Celebrex)South Med J2002951213 2. Gill S, Hermolin RH. Case report of a Stevens-Johnson type reaction to celecoxib. Can J Hosp Pharm 2001; 54( 2): 146(abstr).GillS]]HermolinRHCase report of a Stevens-Johnson type reaction to celecoxibCan J Hosp Pharm200154146 3. Ernst EJ, Egge JA. Celecoxib-induced erythema multiforme with glyburide cross-reactivity. Pharmacotherapy 2002; 22: 637–640.ErnstEJ]]EggeJACelecoxib-induced erythema multiforme with glyburide cross-reactivityPharmacotherapy200222637 4. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129: 92–96.Bastuji-GarinS]]RzanyB]]SternRS]]ShearNH]]NaldiL]]RoujeauJCClinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiformeArch Dermatol199312992
